These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14710439)

  • 21. Respiratory deposition and inhalability of monodisperse aerosols in Long-Evans rats.
    Asgharian B; Kelly JT; Tewksbury EW
    Toxicol Sci; 2003 Jan; 71(1):104-11. PubMed ID: 12520080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract.
    Stahlhofen W; Gebhart J; Heyder J
    Am Ind Hyg Assoc J; 1980 Jun; 41(6):385-98a. PubMed ID: 7395752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particle deposition in children's lungs: theory and experiment.
    Isaacs KK; Martonen TB
    J Aerosol Med; 2005; 18(3):337-53. PubMed ID: 16181008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of respirable metallic oxide aerosols for pulmonary clearance studies in calves.
    Lay JC; Slauson DO
    Cornell Vet; 1987 Oct; 77(4):310-27. PubMed ID: 3446444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
    Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis.
    Brown JS; Zeman KL; Bennett WD
    J Aerosol Med; 2001; 14(4):443-54. PubMed ID: 11791685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
    Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
    BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects.
    Möller W; Barth W; Kohlhäufl M; Häussinger K; Stahlhofen W; Heyder J
    Exp Lung Res; 2001; 27(7):547-68. PubMed ID: 11597117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicomponent aerosol particle deposition in a realistic cast of the human upper respiratory tract.
    Nordlund M; Belka M; Kuczaj AK; Lizal F; Jedelsky J; Elcner J; Jicha M; Sauser Y; Le Bouhellec S; Cosandey S; Majeed S; Vuillaume G; Peitsch MC; Hoeng J
    Inhal Toxicol; 2017 Feb; 29(3):113-125. PubMed ID: 28470142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Difficulties in controlled inhalation of alpha 1-protease inhibitor].
    Brand P; Maas Enriquez M; Meyer T; Scheuch G; Weber N
    Pneumologie; 2003 Mar; 57(3):153-8. PubMed ID: 12632295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung deposition and respirable mass during wet nebulization.
    Sangwan S; Condos R; Smaldone GC
    J Aerosol Med; 2003; 16(4):379-86. PubMed ID: 14977428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between monodisperse Tc-99m-labeled aerosol particles and Kr-81m for the assessment of lung function.
    Short MD; Dowsett DJ; Heaf PJ; Pavia D; Thomson ML
    J Nucl Med; 1979 Mar; 20(3):194-200. PubMed ID: 24180036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.
    Wee WB; Leung K; Coates AL
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):387-96. PubMed ID: 23509934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total deposition of therapeutic particles during spontaneous and controlled inhalations.
    Brand P; Friemel I; Meyer T; Schulz H; Heyder J; Häubetainger K
    J Pharm Sci; 2000 Jun; 89(6):724-31. PubMed ID: 10824130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory flow phenomena and gravitational deposition in a three-dimensional space-filling model of the pulmonary acinar tree.
    Sznitman J; Heimsch T; Wildhaber JH; Tsuda A; Rösgen T
    J Biomech Eng; 2009 Mar; 131(3):031010. PubMed ID: 19154069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of regional deposition of inhaled particles in human lungs by serial bolus delivery method.
    Kim CS; Hu SC; DeWitt P; Gerrity TR
    J Appl Physiol (1985); 1996 Nov; 81(5):2203-13. PubMed ID: 8941546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled, parametric, individualized, 2D and 3D imaging measurements of aerosol deposition in the respiratory tract of healthy human volunteers: in vivo data analysis.
    Majoral C; Fleming J; Conway J; Katz I; Tossici-Bolt L; Pichelin M; Montesantos S; Caillibotte G
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):349-62. PubMed ID: 24400875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease.
    Löndahl J; Swietlicki E; Rissler J; Bengtsson A; Boman C; Blomberg A; Sandström T
    Part Fibre Toxicol; 2012 Jul; 9():30. PubMed ID: 22839109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
    Sagalla RB; Smaldone GC
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.